Subscribe to RSS
DOI: 10.1055/s-0029-1243381
© Georg Thieme Verlag Stuttgart · New York
Ambulante Schmerztherapie. Behandlung bei penetrierendem Rektum-Karzinom mittels Periduralkatheter
Ambulatory pain therapy in penetrating rectal cancer via epidural anesthesiaPublication History
Publication Date:
12 February 2010 (online)
![](https://www.thieme-connect.de/media/ains/201002/lookinside/thumbnails/10.1055-s-0029-1243381-1.jpg)
Zusammenfassung
Im Rahmen der Tumorschmerztherapie kommen immer wieder auch invasive Techniken zum Einsatz. Wir berichten über die Schmerztherapie bei einer 55-jährigen Patientin mit penetrierendem Rektum-Karzinom mittels kontinuierlicher lumbaler Periduralanästhesie. Nach Anlage und Einstellung im Krankenhaus erfolgte die weitere Behandlung über insgesamt 7 Wochen im häuslichen Umfeld.
Abstract
Treatment of cancer pain includes invasive techniques of pain therapy if necessary. Here we report the management of a 55-year-old female patient with penetrating rectal cancer using continous lumbal epidural anesthesia. After placement and dose-finding our patient was discharged from hospital and further treatment occured at home.
Schlüsselwörter
Ambulante Schmerztherapie - palliativ - Periduralkatheter - Rektum-Karzinom
Keywords
Ambulatory pain therapy - palliative - peridural catheter - rectal cancer
Literatur
- 1 Bonica JJ.. Cancer Pain.. In: Fibiger L, (Hrsg.) The Management of Pain.. London/Philadelphia; 1990: 400-460
- 2 Schug SA, Zech D, Dorr U.. Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage. 1990; 5 27-32
- 3 Miguel R.. Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder?. Cancer Control. 2000; 7 149-156
- 4 Jocham HR, Dassen T, Widdershoven G et al.. Quality of life in palliative care cancer patients: a literature review. J Clin Nurs. 2006; 15 1188-1195
- 5 McNicol E, Horowicz-Mehler N, Fisk RA et al.. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003; 4 231-256
- 6 Ohnesorge H, Siebrecht D, Gleim M.. Tumor pain therapy. Anasthesiol Intensivmed Notfallmed Schmerzther. 2003; 38 (Quiz 435–437)
- 7 Kress HG.. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain. 2009; 13 219-230
- 8 Downing JE, Busch EH, Stedman PM.. Epidural morphine delivered by a percutaneous epidural catheter for outpatient treatment of cancer pain. Anesth Analg. 1988; 67 1159-1161
- 9 Smitt PS, Tsafka A, Teng-van de Zande F et al.. Outcome and complications of epidural analgesia in patients with chronic cancer pain. Cancer. 1998; 83 2015-2022
- 10 Ruppen W, Derry S, McQuay HJ, Moore RA.. Infection rates associated with epidural indwelling catheters for seven days or longer: systematic review and meta-analysis. BMC Palliat Care. 2007; 6 3
- 11 Crul BJ, Delhaas EM.. Technical complications during long-term subarachnoid or epidural administration of morphine in terminally ill cancer patients: a review of 140 cases. Reg Anesth. 1991; 16 209-213
Reinhard Abel
Dr. med. Gregor Abt
PD Dr. med. Karl Peter Ittner
Dr. med. Christoph H. R. Wiese
Prof. Dr. med. Bernhard M. Graf
Dr. med. Michael T. Pawlik
Email: reinhard.abel@klinik.uni-r.de
Email: gregor.abt@klinik.uni-r.de
Email: karl-peter.ittner@klinik.uni-r.de
Email: Christoph.Wiese@klinik.uni-regensburg.de
Email: michael.pawlik@klinik.uni-r.de